ADIM
BRKR icon

Alpha DNA Investment Management’s Bruker BRKR Stock Holding History

Alpha DNA Investment Management’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,087
Closed -$1.37M – 110
2021
Q2 		$1.37M Buy
+18,087
New +$1.26M 0.94% 76

Other funds holding BRKR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's BRKR Position: Q3 2021 in Review

Alpha DNA Investment Management sold out of Bruker (BRKR) in Q3 2021, closing a stake of 18,087 shares — an estimated $1.37M sold.

Alpha DNA Investment Management first reported a position in BRKR in Q2 2021 and held it in 1 quarter. The position peaked at $1.37M in Q2 2021. 297 funds tracked by Wall St. Rank hold BRKR as of Q3 2021.

  • Alpha DNA Investment Management reported no remaining Bruker position as of Q3 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 18,087 Bruker shares in Q3 2021, an estimated $1.37M.
  • Alpha DNA Investment Management first reported a position in Bruker in Q2 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Bruker position peaked at $1.37M in Q2 2021.
  • 297 funds tracked by Wall St. Rank held Bruker as of Q3 2021.

Based on Alpha DNA Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.